Volume
45.31M
By late morning
Jupiter Neurosciences Jumps 59% as Volume Hits 59 Times Its Share Count
JUPITER, Florida, August 21, 2026, 11:25 EDT — Jupiter Neurosciences, Inc. surged 59.4% to $8.24 by 11:16:20 EDT. More than 45.3 million shares had changed hands. That volume was about 59 times the company’s entire reported share count.
NASDAQ:JUNS · Investor dashboard
A 59% rally, but a $28.7M listing gap
Market snapshot: August 21, 2026, 11:16:20 EDT (UTC−04:00) · Market open
$8.24▲ 59.38%
Volume / shares
58.8×
Exceptional intraday recycling
Market value
$6.35M
Only 18.1% of Nasdaq threshold
Below day high
26.4%
$8.24 versus $11.20
Nasdaq market-value test
At 770,081 shares, the threshold implies $45.45 per share. That is math, not a price target.
Price path
Previous close$5.17
Friday open$8.23
Session high$11.20
11:16:20 EDT$8.24
High churn · wide $7.66–$11.20 rangeBalance-sheet pressure · six months ended June 30
Cash$1.52M
Operating cash used$3.73M
Net loss$4.34M
Net revenue$42.9K
Cash equaled 40.8% of first-half operating cash use. This is a mechanical comparison, not a runway forecast.
What the move appears to reflect
Fresh SEC filing after August 14No
Reverse split1-for-75 on August 6
Reported shares770,081
Best-supported readTechnical / low-float churn
The trading explanation is an inference from turnover, post-split structure and the absence of a newer disclosure.
Investor checklist
Minimum-bid compliancePrice above $1; formal status still matters
$35M market-value testLarge gap remains
FinancingPotential dilution under existing facility
Clinical valueDepends on future Nugevia/JOTROL evidence
Jupiter Neurosciences (NASDAQ:JUNS) surge cools as $100 million MDMA agreement strains funding resources
Jupiter Neurosciences shares gave up much of an earlier 67% rally on Tuesday after securing U.S. rights for a trial-stage MDMA drug. The stock was up 6.2% at $0.1752 as of 12:50 p.m. EDT.
TechStock² Updates
